908 Devices (MASS) Deferred Taxes (2023 - 2024)
908 Devices (MASS) reported Deferred Taxes of -$73000.0 for Q4 2024, down 10.61% year-over-year from -$81661.0 in Q1 2024, and down 1.39% on a QoQ basis from -$72000.0 in Q3 2024.
908 Devices (MASS) has 2 years of Deferred Taxes data on file, last reported at -$73000.0 in Q4 2024.
- Quarterly Deferred Taxes fell 10.61% year-over-year to -$73000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$283000.0 (up 7.21% YoY) and the FY2024 annual result came in at -$283000.0, up 7.21% from the prior year.
- Deferred Taxes slipped to -$73000.0 in Q4 2024 per MASS's latest filing, from -$72000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at -$50000.0 in Q1 2023 and bottomed at -$117000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -101.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 300,000.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -16.70 Mn |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -68,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | -66,000.00 |
| Sep 30, 2023 | -117,000.00 |
| Jun 30, 2023 | -72,000.00 |
| Mar 31, 2023 | -50,000.00 |